Physicians’ Opinions Survey on FDA’s Bydureon Approval

Report Description

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Nurse Call System Market in the US 2015-2019

Nurse Call System is a communication solution used in healthcare facilities, which enables patients to alert caregivers in case of any routine need or emergency assistance. It serves as the core component of healthcare communication platform and is an innovative, reliable service that alerts the nursing staff through visual and audio signals. It provides the location of the patient in need and indicates the urgency of the call, regardless of the patient's location in the hospital or care center. This not only improves caregiver response time but also creates an environment that is conducive for better patient recovery. The system also allows management and transmission of information within the healthcare facility ensuring continued sustainable care as well as security of patient/resident.......
$2500

Global Male Infertility Market 2015-2019

Infertility is a widespread problem. In male infertility, the male fails to impregnate his female partner after a year of unprotected sex. Male infertility is due to a couple of factors including: Low sperm production Abnormal sperm function or Blockages that prevent the delivery of sperm. Hormonal disturbances to physical problems, or psychological problems can cause male infertility. In most cases, there are no obvious sign or symptoms of an infertility problem. 20 percent of the total infertility is due to male factors. Despite of the scarcity of medicines to treat male infertility, many successful treatment options exist for its many causes. TechNavio's analysts forecast the Global Male Infertility market to grow at a CAGR of 6.60 percent over the period 2014-2019. Cov......
$2500

Global Cystic Fibrosis Market 2015-2019

Cystic fibrosis also known as mucoviscidosis is a genetically-inherited disease. It is one of the most common genetic disorders found in the Caucasian children. The incidence of cystic fibrosis varies among populations, and is substantially less common in Asian and African populations as compared to the people of Caucasoid origin of Europe and North America, with a marked difference within each country. Cystic fibrosis is a chronic disease. The production of a high-salt containing sweat and secretion of abnormal viscous mucus are the major symptoms of cystic fibrosis. TechNavio's analysts forecast the Global Cystic Fibrosis market to grow at a CAGR of 32.50 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects......
$3000

Global Cosmeceuticals Market 2015-2019

Cosmeceuticals are cosmetic products that have medicinal benefits. These products can be purchased over the counter without a doctor's prescription. Cosmeceuticals are discovered as a result of convergence between personal care and pharmaceutical products. TechNavio's analysts forecast the Global Cosmeceuticals market to grow at a CAGR of 8.62 percent over the period 2014-2019. Covered in this Report The Global Cosmeceuticals market can be segmented into six divisions: Skin Care, Hair Care, Injectable, Lip Care, Tooth Whitening, and Others. TechNavio's report, the Global Cosmeceuticals Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the EMEA region, Europe, and the APAC region; it also c......
$2500

Global LBS Market in Healthcare Industry 2015-2019

LBS is an information service that uses real-time geographical data from a location-enabled device to provide security services, and information. LBS applications are predominantly used in hospitals to improve efficiency and reduce expenditure. It works on Wi-Fi and RTLS technology in indoor location. LBS is used in hospitals for indoor navigation, tracking staff and patients, location-based messaging, asset management, location analytics, and in integrating with other clinical systems. TechNavio's analysts forecast the Global LBS market in Healthcare Industry to grow at a CAGR of 31.23 percent over the period 2014-2019. Covered in this Report The Global LBS market in Healthcare Industry can be segmented into four segments: Product, Usage, Technology, and Application. TechNavio......
$2500

Global Telehealth Market 2015-2019

Telehealth is a medium of communication between patients and doctors. Telehealth enables doctors to stay in touch with their patients, monitor their health, and provide consultation if need arises. It includes the use of telecommunication technology in providing medical services to patients especially in remote areas. It is very helpful for the patients who earlier had to travel miles to visit doctors for even minor health issues. Today, doctors can monitor the patients with the help of telehealth devices that keep them updated with all their health information and are capable of communicating necessary advices to the patients. TechNavio's analysts forecast the Global Telehealth market to grow at a CAGR of 18.88 percent over the period 2014-2019. Covered in this Report This report......
$2500

Global Type 2 Diabetes Therapeutics Market 2015-2019

Type 2 diabetes is a chronic condition, which arises due to either the inability of the body to produce enough insulin or insulin resistance, or both. Insulin is a peptide hormone produced by the Islets of Langerhans (pancreatic cells). It is produced in an immature form called preproinsulin, which is proteolytically cleaved to obtain proinsulin and then insulin. Type 2 diabetes nearly accounts for 90-95 percent of the total diabetic cases. Type 2 diabetes is usually diagnosed in middle-aged and older people; however, it can occur even during childhood. Type 2 diabetes was also known as adult-onset diabetes or non-insulin-dependent diabetes. Risk factors for type 2 diabetes include high blood pressure, advancing age, overweight, history of gestational diabetes, family history of diabetes, ......
$3000

Global Herpes Market 2014-2018

Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through contact. At present, there is no cure for herpes, however, treatments can help reduce the pain and decrease healing period. TechNavio's analysts forecast the Global Herpes market to grow at a CAGR of 10.14 percent over the period 2013-2018. Covered in this Report This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from th......
$2500

Global Pharmaceuticals Wholesale and Distribution Market 2015-2019

The pharmaceutical wholesale and distribution process involves the storage as well as the movement of pharmaceutical products from manufacturing plants to wholesalers, hospitals/clinics, or patients. Pharmaceutical products producers maintain strong partnerships with 3PL providers to encourage efficient and cost-effective metrics. Companies dealing with the distribution of pharmaceutical products comply with strict government regulations, as pharmaceutical products ought to reach patients in usable form so that they may not affect a patient's health. Vigilance at every phase of distribution of pharmaceutical products contributes to their safety record. In some cases, companies might also choose to spur their distribution process through outsourcing, as it is convenient and cost effective. ......
$2500

Osteoporosis Drugs Market in the APAC Region 2015-2019

Osteoporosis is a disease that reduces of the mass and density of bone, and results in increased risk of fracture. In this disease, the risks related to fracture increases because of the increased permeability of the bones. Often, there are no symptoms observed until the first fracture occurs. Increase in age, low body weight, low sex hormones or menopause, and smoking are some of the risk factors associated with this disease. TechNavio's analysts forecast the Osteoporosis Drugs market in APAC to grow at a CAGR of 4.73 percent over the period 2014-2019. Covered in this Report The Osteoporosis Drugs market in APAC can be divided into two segments: Antiresorptives and Anabolics. This report covers the present scenario and the growth prospects of the Osteoporosis Drugs market in APAC......
$2500